SG
SARAH GUERRIERI
THE CHILDREN'S HOSPITAL OF PHILADELPHIA · Philadelphia, PA · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
5 agencies contacted
Activity
filings by quarter
Works on
Specific issues
H.R. 9029 and S. 4942 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, egarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Advanced Research Projects !Agency-Health, and other programs related to pediatric health care Funding for cell and gene therapy generally
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Children's Hospital GME Support Reauthorization Act of2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids' Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions H.R. I 0545 (American Relief Act, 2025), regarding HHS program funding and Medicaid program reform provisions National Institutes of Health program reforms generally S. 904 (Sickle Cell Disease Comprehensive Care Act), all provisions
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally "Food as medicine" nutrition programs generally Advanced Research Projects Agency-Health program generally H.R. 3884 and S. 1852 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Children's Hospital GME Support Reauthorization Act of2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4758 (Accelerating Kids' Access to Care Act), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of2024), all provisions H.R. 8260 and S. 4350 (Hospital Inpatient Services Modernization Act), all provisions Pediatric organ procurement and transplant policies generally Violence prevention programs generally
H.R. 9029 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025), Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Advanced Research Projects Agency-Health, and other programs related to pediatric health care
Medicaid program reforms, including telemedicine and prior authorization issues Section 340B Drug Pricing program, including H.R. 5378 (Lower Costs, More Transparency Act), Section 202 Drug pricing reforms generally Juvenile mental and behavioral health legislation generally Gun violence prevention programs generally "Food as medicine" nutrition programs generally Advanced Research Projects Agency-Health program generally H.R. 3884 (Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023), all provisions H.R. 3391 (Gabriella Miller Kids First Research Act 2.0), all provisions H.R. 3887 (Children's Hospital GME Support Reauthorization Act of 2023), all provisions Medicare "site neutral" payment policy generally, including H.R. 5378 (Lower Costs, More Transparency Act), Section 203 Pediatric cancer research generally Pediatric access to cell and gene therapies generally H.R. 4822 (Health Care Price Transparency Act of 2023), all provisions H.R. 7808 (EARLY Minds Act), regarding pediatric mental health H.R. 4758 (Accelerating Kids Access to Care Act), all provisions Laboratory developed tests generally, including H.R. 2369 (Verifying Accurate Leading-edge IVCT Development Act of 2023), all provisions H.R. 7213 (Autism Collaboration, Accountability, Research, Education, and Support Act of 2024), all provisions
H.R. 5894 and S. 2624 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024), Title II, regarding National Institutes of Health funding, Children's Hospitals Graduate Medical Education (CHGME) program, Advanced Research Projects Agency-Health, and other programs related to pediatric health care H.R. 2882 (Further Consolidated Appropriations Act, 2024), Division D, Title II, regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Advanced Research Projects Agency-Health, and other programs related to pediatric health care Fiscal Year 2025 Department of Health and Human Services funding regarding National Institutes of Health funding, Children's Hospital Graduate Medical Education (CHGME) program, Advanced Research Projects Agency-Health, and other programs related to pediatric health care